Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Lawrence RiceWeill Cornell Medical College, The Methodist Hospital, Houston, Texas, USAAbstract: Immune thrombocytopenic purpura (ITP) is a relatively common autoimmune disorder in which antibodies are produced to circulating platelets. Symptoms can be mild, but for most patients the risk of severe...
Saved in:
Main Author: | Lawrence Rice |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/6c28fca0d9f74d4d9876a2b6c8052885 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
by: Ara Metjian, et al.
Published: (2009) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
by: Zahid Farooq Baig, et al.
Published: (2018) -
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
by: Andreas Rank, et al.
Published: (2010) -
A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke
by: Mark E. Pepin, et al.
Published: (2021) -
Aseptic meningitis after intravenous immunoglobulin (IVIG) infusion in children with immune thrombocytopenic purpura (ITP)
by: A Tamaddoni, et al.
Published: (2001)